ENTRY       D11289                      Drug
NAME        Rivoceranib mesylate (USAN);
            Alitan (TN)
FORMULA     C24H23N5O. CH4SO3
EXACT_MASS  493.1784
MOL_WEIGHT  493.578
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
REMARK      Chemical structure group: DG02966
EFFICACY    Antineoplastic, Receptor tyrosine kinase inhibitor
TARGET      VEGFR2 (KDR) [HSA:3791] [KO:K05098]
  PATHWAY   hsa04010(3791)  MAPK signaling pathway
            hsa04151(3791)  PI3K-Akt signaling pathway
            hsa04370(3791)  VEGF signaling pathway
INTERACTION  
BRITE       Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG02966  Rivoceranib
                 D11289  Rivoceranib mesylate
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               VEGFR family
                VEGFR2 (KDR)
                 D11289  Rivoceranib mesylate (USAN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG02966  Rivoceranib
DBLINKS     CAS: 1218779-75-9
            PubChem: 384585267
ATOM        35
            1   C8y C    22.9697  -17.0353
            2   C8x C    21.7130  -17.8033
            3   C8x C    20.5261  -16.9655
            4   C8y C    20.5261  -15.6390
            5   C8x C    21.7130  -14.9408
            6   C8x C    22.9697  -15.6390
            7   N1b N    19.3393  -14.8710
            8   C5a C    18.0825  -15.5691
            9   O5a O    18.0825  -16.9655
            10  C8y C    16.8957  -14.8710
            11  C8y C    15.7088  -15.5691
            12  N5x N    14.5219  -14.8710
            13  C8x C    14.5219  -13.4746
            14  C8x C    15.7088  -12.7765
            15  C8x C    16.8957  -13.4746
            16  N1b N    15.7088  -16.9655
            17  C1b C    14.5219  -17.6636
            18  C8y C    13.3350  -17.0353
            19  C8x C    13.3350  -15.5691
            20  C8x C    12.0783  -14.8710
            21  N5x N    10.8914  -15.5691
            22  C8x C    10.8914  -17.0353
            23  C8x C    12.0783  -17.7335
            24  C1z C    24.2264  -17.8033
            25  C1x C    24.2264  -19.1996
            26  C1x C    25.5529  -19.5487
            27  C1x C    26.3209  -18.4316
            28  C1x C    25.4831  -17.3146
            29  C3b C    24.2264  -16.4069
            30  N3a N    24.2264  -15.0106
            31  S4a S    29.8200  -17.1500
            32  O1d O    29.8200  -15.7500
            33  O1d O    29.8200  -18.5500
            34  C1a C    28.4200  -17.1500
            35  O1d O    31.2200  -17.1500
BOND        37
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 2
            10    8  10 1
            11   10  11 2
            12   11  12 1
            13   12  13 2
            14   13  14 1
            15   14  15 2
            16   10  15 1
            17   11  16 1
            18   16  17 1
            19   17  18 1
            20   18  19 2
            21   19  20 1
            22   20  21 2
            23   21  22 1
            24   22  23 2
            25   18  23 1
            26    1  24 1
            27   24  25 1
            28   25  26 1
            29   26  27 1
            30   27  28 1
            31   24  28 1
            32   24  29 1
            33   29  30 3
            34   31  32 2
            35   31  33 2
            36   31  34 1
            37   31  35 1
///
